Atoosa Molanazadeh, PA
Physician Assistant · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Sutter Lakeside Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Atoosa Molanazadeh’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C14589 · Cancelled
Licence status: Cancelled · since 1953 · University of Wisconsin Medical School.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Lakeside HospitalLakeport, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Lakeside Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 8.7 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 133 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 379 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 31 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.249 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -25.4 · 92 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -37.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.3) · 564 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (209 patients answered, 18% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 58% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$99,871
Medicare paid this office $99,871 for 665 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 401 | $57,736 | $119 |
| Return visit (30+ min) | 175 | $16,601 | $86 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 459 | $6,398 | $11 |
| Transitional care management services for problem of at least moderate complexity | 29 | $4,457 | $154 |
| New patient visit (45+ min) | 33 | $3,849 | $117 |
See all 9 services
| Long return visit (40+ min) | 401 | $57,736 | $119 |
| Return visit (30+ min) | 175 | $16,601 | $86 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 459 | $6,398 | $11 |
| Transitional care management services for problem of at least moderate complexity | 29 | $4,457 | $154 |
| New patient visit (45+ min) | 33 | $3,849 | $117 |
| New patient visit (60+ min) | 20 | $3,202 | $160 |
| New patient visit (30+ min) | 41 | $3,013 | $73 |
| Short return visit (20+ min) | 35 | $1,853 | $53 |
| Heart rhythm recording of continous external ekg over 8-15 days | 30 | $329 | $11 |
Who their Medicare patients are
665 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 14% · Women 56% · Also on Medicaid 17% · Health risk score 1.47. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Coronary heart disease 49% · Atrial fibrillation 42% · Heart failure 34% · Diabetes 29% · Chronic kidney disease 28% · Depression 21% · COPD 17% · Cancer 16% · Stroke 11% · Dementia 4%.
The office billed $450,488, Medicare allowed $136,922 and paid $99,871; for 1,466 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 665 | 1,466 | 76 | 1.47 | $450,488 | $99,871 |
| 2023 | 218 | 285 | 76 | 1.45 | $113,929 | $29,314 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 158 | $21,124 | $128 |
| Return visit (30+ min) | 47 | $4,534 | $93 |
| Short return visit (20+ min) | 11 | $666 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 32 | $345 | $10 |
Drugs they prescribed that Part D paid
$442,484
Pharmacies billed $442,484 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,165) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
1,737 generic and 428 brand-name prescriptions · $442,484 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 109 | $127,328 | $1,168 |
| Entresto | 87 | $92,145 | $1,059 |
| Farxiga | 84 | $77,183 | $919 |
| Jardiance | 53 | $56,762 | $1,071 |
| Repatha Sureclick | 32 | $25,037 | $782 |
See all 32 drugs
| Eliquis | 109 | $127,328 | $1,168 |
| Entresto | 87 | $92,145 | $1,059 |
| Farxiga | 84 | $77,183 | $919 |
| Jardiance | 53 | $56,762 | $1,071 |
| Repatha Sureclick | 32 | $25,037 | $782 |
| Brilinta | 14 | $9,519 | $680 |
| Praluent | 11 | $7,119 | $647 |
| Ezetimibe | 110 | $3,866 | $35 |
| Atorvastatin | 323 | $3,864 | $12 |
| Metoprolol | 202 | $2,646 | $13 |
| Rosuvastatin | 103 | $1,636 | $16 |
| Amiodarone | 18 | $1,547 | $86 |
| Metoprolol | 47 | $1,080 | $23 |
| Amlodipine Besylate | 145 | $1,033 | $7 |
| Losartan | 115 | $800 | $7 |
| Diltiazem 24hr Er (Cd) | 26 | $703 | $27 |
| Lisinopril | 72 | $622 | $9 |
| Sotalol | 22 | $532 | $24 |
| Furosemide | 89 | $510 | $6 |
| Pravastatin | 17 | $477 | $28 |
| Hydrochlorothiazide | 93 | $469 | $5 |
| Digoxin | 13 | $443 | $34 |
| Spironolactone | 61 | $439 | $7 |
| Valsartan | 16 | $364 | $23 |
| Carvedilol | 28 | $295 | $11 |
| Clopidogrel | 19 | $266 | $14 |
| Potassium Chloride | 26 | $254 | $10 |
| Hydralazine | 15 | $164 | $11 |
| Nitroglycerin | 14 | $124 | $9 |
| Diltiazem | 12 | $83 | $7 |
| Isosorbide Mononitrate Er | 21 | $71 | $3 |
| Benazepril | 13 | $68 | $5 |
Year by year
| 2024 | 2,165 | 490 | 0% (0) | 20% | $442,484 |
| 2023 | 277 | 123 | 0% (0) | 17% | $48,657 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Entresto | 17 | $16,839 | $991 |
| Eliquis | 12 | $8,989 | $749 |
| Atorvastatin | 18 | $424 | $24 |
| Metoprolol | 23 | $402 | $17 |
| Rosuvastatin | 15 | $249 | $17 |
| Potassium Chloride | 13 | $208 | $16 |
| Losartan | 26 | $201 | $8 |
| Amlodipine Besylate | 16 | $186 | $12 |
| Hydrochlorothiazide | 17 | $108 | $6 |
| Lisinopril | 14 | $99 | $7 |
| Furosemide | 18 | $96 | $5 |
Money from drug and device companies
$866 in 2025
| 2025 | 5 | 13 | None | $866 |
| 2024 | 7 | 12 | None | $520 |
| 2023 | 6 | 9 | None | $274 |
| 2022 | 2 | 7 | None | $869 |
| 2021 | 1 | 10 | None | $1,531 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Symplicity G3 | $710 | 8 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $56 | 2 payments
|
| Philips North America | Mcot | $46 | 1 payment
|
| Amgen | Repatha | $32 | 1 payment
|
| Esperion Therapeutics | Nexletol | $22 | 1 payment
|
See all 13 published payments
| Medtronic | Meals · 2025-12-19 | Symplicity G3 | $114 |
| Medtronic | Travel · 2025-12-16 | Symplicity G3 | $100 |
| Medtronic | Travel · 2025-12-16 | Symplicity G3 | $20 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-04 | Jardiance | $23 |
| Medtronic | Meals · 2025-10-01 | Micra | $154 |
| Medtronic | Travel · 2025-09-26 | Micra | $99 |
| Amgen | Meals · 2025-09-24 | Repatha | $32 |
| Medtronic | Meals · 2025-07-10 | Symplicity G3 | $135 |
| Medtronic | Meals · 2025-05-27 | Micra | $52 |
| Philips North America | Meals · 2025-04-18 | Mcot | $46 |
| Medtronic | Meals · 2025-03-04 | Micra | $36 |
| Esperion Therapeutics | Meals · 2025-02-11 | Nexletol | $22 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-02-06 | Jardiance | $33 |
See earlier years (2024, 2023, 2022, 2021)
2024: $520
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $147 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $140 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $105 | 1 payment
|
| iRhythm Technologies | Zio Monitor | $54 | 3 payments
|
| Philips North America | (5044) Mcot | $43 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $18 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $13 | 2 payments
|
2023: $274
| Boston Scientific | Watchman Flx | $157 | 3 payments
|
| Medtronic | Micra | $41 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $25 | 1 payment
|
| Esperion Therapeutics | Nexletol | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $12 | 2 payments
|
2022: $869
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $697 | 6 payments
|
| Boston Scientific | General - Therapies | $173 | 1 payment
|
2021: $1,531
| Medtronic | Corevalve Evolut | $1,531 | 10 payments
|
Professional record
- NPI
- 1619404431
- Licence
- CA 14589California C14589: Cancelled
- Trained
- Stanford University School of Medicine, 1998
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-05-11
- NPI last updated
- 2023-05-18
- NPI record certified
- 2023-05-18
This is when the NPI record was last certified, not a medical board exam.